01
Nanomedicine
Research into nanoparticle-based diagnostics and therapeutics that act selectively within complex biological systems.
INTERNATIONAL NANOTME SOCIETY — LAUNCHED 2025 - CONFERENCES SINCE 2021
Where nanomedicine meets the tumor microenvironment.
An international scientific society convening researchers, clinicians, industry leaders and students to shape the next generation of cancer therapies — across disciplines, across continents.
Society launched
2025
Conference since
2021
Editions held
3
Disciplines
Nanomedicine · Tumor Microenvironment
The Society
Advancing a rapidly evolving field.
The tumor microenvironment shapes how cancers grow, spread, and respond to therapy. Nanomedicine offers an unprecedented set of tools to act within that environment — precisely, selectively, and adaptively. The NanoTME Society exists to accelerate the exchange between these two disciplines, and to translate that exchange into better outcomes for patients.
Scientific collaboration
Convening nano-engineers, immunologists, oncologists and clinicians around shared questions and shared standards.
Translational research
Carrying discoveries across the gap that separates the bench from the bedside.
Education & training
Supporting the next generation through conferences, workshops and mentorship programs.
International networking
A working network of institutions across academia, hospitals and industry.
A note from the co-chairs
“The interface between nanomedicine and the tumor microenvironment is where the most consequential questions in cancer therapy are now being asked. Our Society exists so that the answers can be found together — across laboratories, hospitals, disciplines, and borders.”
Prof. dr. Jai Prakash
Co-chair
Prof. dr. Yuval Shaked
Co-chair
Scientific focus areas
Six disciplines working on the same shared frontier.
02
Tumor microenvironment
Understanding the cellular and molecular interactions that influence disease progression and treatment response.
03
Cancer immunotherapy
Novel strategies leveraging immune modulation and targeted delivery systems for durable response.
04
Advanced tumor models
Development of sophisticated in vitro and in vivo systems that faithfully reflect human disease.
05
Drug delivery technologies
Innovative approaches for precise therapeutic targeting across tissue and cellular barriers.
06
Translational oncology
Bridging fundamental discoveries and clinical applications to improve patient outcomes.
Past Events and Upcoming Conference
The NanoTME meeting — the field's principal scientific gathering.
Conference programme
- Keynote lectures from leading international investigators
- Short talks selected from open abstract review
- Curated poster sessions with travel awards
- Industry showcases and translational round-tables
- Early-career mentoring and structured networking
2021
Inaugural edition — online
International audience · founding scientific dialogue
2023
2nd edition — UPark, University of Twente
8 — 10 May · in collaboration with the ICMS
2025
3rd edition — Van der Valk, Enschede
5 — 8 May · 22 invited speakers · 14 short talks · +100 participants
Upcoming events
The conference, and the work that continues year-round.
Featured
NanoTME Conference
Three days of keynote lectures, scientific sessions, posters, workshops and structured networking — convening the global community in one place.
- Keynote lectures
- Scientific sessions
- Poster presentations
- Workshops
- Networking opportunities
- Industry engagement
Flagship
NanoTME Conference
5 — 8 May 2025 · Van der Valk Hotel, Enschede, The Netherlands
Webinar
NanoTME Webinar Series
Quarterly · Online
Training
Summer Training School
Summer · Rotating host institutions
Membership
Affiliation with an international scientific society.
01
Principal investigators
Academic scientists leading independent research programmes in nanomedicine, tumor microenvironment biology and translational oncology.
02
Clinician scientists
Oncologists and physician-investigators contributing clinical perspective and access to translational questions.
03
Industry & translational partners
Biotechnology, pharmaceutical and instrumentation organisations engaged in the translation of nanomedicine.
04
Early-career members
PhD candidates, postdoctoral researchers and clinical fellows participating in the scientific life of the Society.
Member benefits
Membership is an affiliation with a working scientific community — built around collaboration, visibility and participation in the Society's programme.
Become a membercoming soon- Scientific collaboration with peer institutions
- Visibility across the international community
- Priority access to the NanoTME conference
- Participation in scientific working groups
- Eligibility for committee and leadership roles
- Structured exchange with affiliated societies
Society leadership
Founded by scientists. Convened for the community.
Co-chair
Prof. dr. Yuval Shaked
A long-standing research programme on the systemic and microenvironmental response of the host to anti-cancer therapy, and on the mechanisms by which treatment shapes resistance and metastasis.
Research focus
Host response to anti-cancer therapy · tumor microenvironment · resistance mechanisms
“The interface between nanomedicine and the tumor microenvironment is where the most consequential questions in modern oncology are now being asked. The Society exists so that those questions can be addressed together.”
Co-chair
Prof. dr. Jai Prakash
A research programme on stromal targeting and engineered nanomedicine for solid tumors, with a translational orientation across academia, clinic and industry.
Research focus
Targeted nanomedicine · stromal targeting · advanced 3D tumor models
“NanoTME was conceived as a working community. Three editions in, it has become the place where engineers, biologists and clinicians can speak the same language — and design experiments together.”
Scientific advisory board
Coming soon.
A short history
2021
Inaugural online conference
The first NanoTME conference is held online, drawing an enthusiastic international audience and laying the groundwork for an ongoing scientific dialogue at the interface of nanomedicine and the tumor microenvironment.
2023
2nd edition — first in-person
NanoTME 2023 is held 8 — 10 May at the UPark hotel on the University of Twente campus, in collaboration with the International Cancer Microenvironment Society.
2025
3rd edition & Society launched
NanoTME 2025 takes place 5 — 8 May at the Van der Valk hotel in Enschede with 22 invited speakers, 14 short talks, ~35 posters and ~75 participants worldwide. Yuval Shaked and Jai Prakash officially launch the NanoTME Society.
2025—
Working groups & institutional partnerships
The Society formalises cross-institutional working groups, opens membership to investigators worldwide, and establishes structured collaborations with affiliated scientific societies.
Next
Looking ahead — 4th edition & beyond
Planning is underway for the next edition of the NanoTME conference, expanded educational programming for early-career members, and continued growth of the international scientific community.
Vision
The global home of the field
Across the coming decade, the Society aims to become the established international home for research at the interface of nanomedicine and the tumor microenvironment — anchoring collaboration, education and translation.
Featured research
The science that the Society convenes, and continues to advance.
Conference proceedings
NanoTME 2025
Twenty-two invited lectures and fourteen selected short talks across nanomedicine, tumor microenvironment biology, and translational oncology, with proceedings curated by the scientific committee.
Member publications
A connected body of work
Society members publish across leading journals in cancer research, drug delivery and immuno-oncology, with collaborative manuscripts emerging directly from conference exchanges.
Emerging directions
Engineering the microenvironment
Current scientific priorities include stromal targeting, immune modulation through nano-carriers, advanced 3D tumor models, and the rational design of combination therapies.
Collaborative initiatives
Cross-institutional working groups
Working groups formed at NanoTME meetings continue between editions as co-authored studies, joint grant applications and shared training programs.
Global network
A working community across more than fifteen countries.
Europe
Netherlands · Germany · United Kingdom · Italy · Spain · Switzerland · Belgium · France
Middle East
Israel
North America
United States · Canada
Asia–Pacific
India · China · Japan · Singapore · Australia
News & announcements
The latest from the Society and the wider community.
Announcement
Read →The next NanoTME conference: 3–5 May 2027, University of Giessen
The Society is pleased to announce that the fourth edition of the NanoTME conference will be held on 3–5 May 2027 at the campus of the University of Giessen, Germany. Details of the scientific programme and registration will follow.
Join us
A scientific community for the next chapter of cancer research.
Affiliation with the NanoTME Society places investigators, clinicians and partners within an international scientific community working at the interface of nanomedicine and the tumor microenvironment.